Perrigo Co. PLC (PRGO): Price and Financial Metrics

Perrigo Co. PLC (PRGO): $34.57

-0.38 (-1.09%)

POWR Rating

Component Grades














  • PRGO scores best on the Growth dimension, with a Growth rank ahead of 85.14% of US stocks.
  • PRGO's strongest trending metric is Quality; it's been moving up over the last 178 days.
  • PRGO's current lowest rank is in the Momentum metric (where it is better than 9.24% of US stocks).

PRGO Stock Summary

  • PERRIGO CO PLC's market capitalization of $4,681,725,737 is ahead of 75.52% of US-listed equities.
  • PRGO's went public 31.28 years ago, making it older than 84.23% of listed US stocks we're tracking.
  • Over the past twelve months, PRGO has reported earnings growth of -98.39%, putting it ahead of just 14.67% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to PERRIGO CO PLC, a group of peers worth examining would be CMCO, MTX, OC, HAYW, and IAC.
  • Visit PRGO's SEC page to see the company's official filings. To visit the company's web site, go to

PRGO Valuation Summary

  • In comparison to the median Healthcare stock, PRGO's EV/EBIT ratio is 17261.83% higher, now standing at 1137.2.
  • PRGO's EV/EBIT ratio has moved up 1129.4 over the prior 243 months.

Below are key valuation metrics over time for PRGO.

Stock Date P/S P/B P/E EV/EBIT
PRGO 2023-03-17 1.1 1 -33.3 1137.2
PRGO 2023-03-16 1.1 1 -34.2 1154.4
PRGO 2023-03-15 1.1 1 -34.1 1152.5
PRGO 2023-03-14 1.1 1 -34.4 1158.7
PRGO 2023-03-13 1.1 1 -33.8 1146.5
PRGO 2023-03-10 1.1 1 -34.3 1157.4

PRGO Growth Metrics

    Its 4 year net cashflow from operations growth rate is now at -6.25%.
  • The 5 year price growth rate now stands at -23.53%.
  • Its 2 year cash and equivalents growth rate is now at 285.09%.
Over the past 15 months, PRGO's revenue has gone up $128,300,000.

The table below shows PRGO's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 4,451.6 307.3 -140.6
2022-09-30 4,401.3 16 -107.3
2022-06-30 4,343.8 300.6 -116.8
2022-03-31 4,203.2 235.2 -109.4
2021-12-31 4,138.7 156.3 -68.9
2021-09-30 4,323.3 372.1 -253.5

PRGO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • PRGO has a Quality Grade of D, ranking ahead of 9.21% of graded US stocks.
  • PRGO's asset turnover comes in at 0.394 -- ranking 119th of 682 Pharmaceutical Products stocks.
  • TMBR, OCUP, and ORMP are the stocks whose asset turnover ratios are most correlated with PRGO.

The table below shows PRGO's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-07-03 0.394 0.359 -0.038
2021-04-03 0.407 0.359 -0.012
2020-12-31 0.435 0.359 -0.003
2020-09-26 0.439 0.358 0.026
2020-06-27 0.440 0.357 0.064
2020-03-28 0.440 0.361 0.058

PRGO Stock Price Chart Interactive Chart >

Price chart for PRGO

PRGO Price/Volume Stats

Current price $34.57 52-week high $43.90
Prev. close $34.95 52-week low $30.78
Day low $34.25 Volume 1,886,600
Day high $35.67 Avg. volume 1,117,374
50-day MA $36.47 Dividend yield 3.12%
200-day MA $37.53 Market Cap 4.65B

Perrigo Co. PLC (PRGO) Company Bio

Perrigo Company plc is an American Irish–registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. (Source:Wikipedia)

PRGO Latest News Stream

Event/Time News Detail
Loading, please wait...

PRGO Latest Social Stream

Loading social stream, please wait...

View Full PRGO Social Stream

Latest PRGO News From Around the Web

Below are the latest news stories about PERRIGO CO PLC that investors may wish to consider to help them evaluate PRGO as an investment opportunity.

Perrigo gains amid new long call at Hedgeye

  • Perrigo (NYSE:PRGOrose 1.4% amid a new long idea at Hedgeye as the analyst sees the challenges of 2022 behind the company.
  • "With depleted inventory levels at retail for Cough & Cold, a better outlook for Oral Care from lower freight rates, additional Infant Formula production capacity (better for revenue growth and margins), continued synergies from HRA, and margin recapture from pricing initiatives Perrigo's 2023 is set up to put the challenges of 2022 behind," Hedgeye analyst Daniel Biolsi wrote in a note late Friday.
  • "Management’s three-ye...

    Seeking Alpha | March 20, 2023

Some Gerber Baby Formula Recalled Due to Possible Contamination

Perrigo says the decision affects certain lots of Gerber Good Start SoothePro powdered variety that was made at its plant in Eau Claire, Wis.

Yahoo | March 20, 2023

Perrigo to Present at Upcoming 12th Annual UBS Global Consumer and Retail Conference

Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO, Murray S. Kessler and CFO Eduardo Bezerra are scheduled to present at the 12th Annual UBS Global Consumer and Retail Conference in New York City on Wednesday, March 15th at 3:00 PM EST.

Yahoo | March 2, 2023

Perrigo Announces FDA Approval of the Store Brand OTC Equivalent of Advil® Dual Action Tablets

Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it has received final approval from the U.S. Food and Drug Administration ("FDA") for its Abbreviated New Drug Application ("ANDA") for Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg, the store brand over-the-counter ("OTC") equivalent of Advil® Dual Action Tablets 250 mg/125 mg. The Company anticipates launching the product by Spring 2023.

Yahoo | March 1, 2023

16 Best Consistent Dividend Stocks to Buy

In this article, we discuss 16 best consistent dividend stocks to buy. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read 5 Best Consistent Dividend Stocks to Buy. Income-generating stocks are all the rage as the stock market suffered huge losses last year. According […]

Yahoo | February 28, 2023

Read More 'PRGO' Stories Here

PRGO Price Returns

1-mo N/A
3-mo 9.00%
6-mo -7.82%
1-year -6.35%
3-year -11.73%
5-year -52.36%
YTD 2.16%
2022 -9.78%
2021 -10.95%
2020 -11.97%
2019 35.65%
2018 -55.08%

PRGO Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full PRGO Dividend History

Continue Researching PRGO

Here are a few links from around the web to help you further your research on PERRIGO Co plc's stock as an investment opportunity:

PERRIGO Co plc (PRGO) Stock Price | Nasdaq
PERRIGO Co plc (PRGO) Stock Quote, History and News - Yahoo Finance
PERRIGO Co plc (PRGO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8515 seconds.